Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-10-29

FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Granules Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for a Losartan Potassium product from Granules Pharmaceuticals Inc., enabling a generic losartan potassium formulati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Losartan Potassium (Losartan potassium)

Snippet

SUPPL AP for LOSARTAN POTASSIUM (LOSARTAN)